Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beneke

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Clinical Pharmacology|January 1, 1992
Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteersM Beneke, W Wingender, R Horstmann, et al.
Arzneimittel-Forschung|March 1, 1996
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparationsM Bagli, M L Rao, G Höflich, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Nimodipine in subcortical vascular dementia trialR Rossi, D Inzitari, L Pantoni, et al.
Psychopharmacology|November 18, 2006
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidolM Reimold, C Solbach, S Noda, et al.
Neuropsychobiology|February 28, 2003
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patientsI Hertling, M Philipp, A Dvorak, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Clinical Pharmacology|January 1, 1992
Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteersM Beneke, W Wingender, R Horstmann, et al.
Arzneimittel-Forschung|March 1, 1996
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparationsM Bagli, M L Rao, G Höflich, et al.
Alzheimer Disease and Associated Disorders|December 28, 1999
Nimodipine in subcortical vascular dementia trialR Rossi, D Inzitari, L Pantoni, et al.
Psychopharmacology|November 18, 2006
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidolM Reimold, C Solbach, S Noda, et al.
Neuropsychobiology|February 28, 2003
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patientsI Hertling, M Philipp, A Dvorak, et al.
Pageof 3